Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?

التفاصيل البيبلوغرافية
العنوان:	Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
المؤلفون:	Weiss, Lena^{Aff1, Aff2}, Heinemann, Volker^{Aff1, Aff2, Aff3}, Fischer, Laura E.^{Aff1, Aff2}, Gieseler, Frank, Hoehler, Thomas, Mayerle, Julia^{Aff2, Aff6}, Quietzsch, Detlef, Reinacher-Schick, Anke, Schenk, Michael, Seipelt, Gernot, Siveke, Jens T.^{Aff11, Aff15}, Stahl, Michael, Vehling-Kaiser, Ursula, Waldschmidt, Dirk T., Dorman, Klara^{Aff1, Aff2, Aff3}, Zhang, Danmei^{Aff1, Aff2, Aff3}, Westphalen, C. Benedikt^{Aff1, Aff2}, von Bergwelt-Baildon, Michael^{Aff1, Aff2, Aff3}, Boeck, Stefan^{Aff1, Aff2, Aff3}, Haas, Michael^{Aff1, Aff2, IDs12094023033231_cor20}
المصدر:	Clinical and Translational Oncology. 26(5):1268-1272
قاعدة البيانات:	Springer Nature Journals

الوصف
تدمد:	16993055
DOI:	10.1007/s12094-023-03323-1